secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRC HEALTH (NRC)
CIK:        0000070487
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0001437749-22-025653
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

National Research Corp Q3 revenue flat at $37.7M; EPS down to $0.33 from $0.38
------------------------------------------------------------------------------

- Revenue $37.7M vs $37.8M prior year; net income $8.3M vs $9.7M; diluted EPS $0.33 vs $0.38.
- CFO cited investments in innovation, marketing, and associate retention as margin headwinds.
- Canadian operations phase-out and non-core decline offset core growth.
- Paid $5.9M in dividends and $3.6M for share repurchases in Q3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/70487/000143774922025653/0001437749-22-025653-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/70487/000143774922025653/nrc20221102_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-025653

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer